122 related articles for article (PubMed ID: 17499237)
21. Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts.
Chan P; Liu JC; Lin LJ; Chen PY; Cheng TH; Lin JG; Hong HJ
Am J Chin Med; 2011; 39(2):381-94. PubMed ID: 21476213
[TBL] [Abstract][Full Text] [Related]
22. Vasodilatory and anti-inflammatory effects of the 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG) via a nitric oxide-cGMP pathway.
Kang DG; Moon MK; Choi DH; Lee JK; Kwon TO; Lee HS
Eur J Pharmacol; 2005 Nov; 524(1-3):111-9. PubMed ID: 16253226
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide modulates intracellular translocation of pigment organelles in Xenopus laevis melanophores.
Nilsson HM; Karlsson AM; Loitto VM; Svensson SP; Sundqvist T
Cell Motil Cytoskeleton; 2000 Nov; 47(3):209-18. PubMed ID: 11056522
[TBL] [Abstract][Full Text] [Related]
24. Role of nitric oxide on atrial natriuretic peptide release induced by angiotensin II in superfused rat atrial tissue.
Soualmia H; Barthélemy C; Eurin J; Masson F; Carayon A
Regul Pept; 2001 Apr; 98(3):105-10. PubMed ID: 11231039
[TBL] [Abstract][Full Text] [Related]
25. [Molecular mechanism of nitric oxide in preventing cardiomyocytes from hypertrophic response induced by angiotensin II].
Liu PQ; Lu W; Pan JY
Sheng Li Xue Bao; 2002 Jun; 54(3):213-8. PubMed ID: 12075467
[TBL] [Abstract][Full Text] [Related]
26. Unravelling the cardiovascular effects induced by alpha-terpineol: a role for the nitric oxide-cGMP pathway.
Ribeiro TP; Porto DL; Menezes CP; Antunes AA; Silva DF; De Sousa DP; Nakao LS; Braga VA; Medeiros IA
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):811-6. PubMed ID: 20374260
[TBL] [Abstract][Full Text] [Related]
27. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942
[TBL] [Abstract][Full Text] [Related]
28. 5-hydroxytryptamine- and U46619-mediated vasoconstriction in bovine pulmonary conventional and supernumerary arteries: effect of endogenous nitric oxide.
Bunton D; MacDonald A; Brown T; Tracey A; McGrath JC; Shaw AM
Clin Sci (Lond); 2000 Jan; 98(1):81-9. PubMed ID: 10600662
[TBL] [Abstract][Full Text] [Related]
29. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
[TBL] [Abstract][Full Text] [Related]
30. Regulation of ciliary beat frequency by the nitric oxide-cyclic guanosine monophosphate signaling pathway in rat airway epithelial cells.
Li D; Shirakami G; Zhan X; Johns RA
Am J Respir Cell Mol Biol; 2000 Aug; 23(2):175-81. PubMed ID: 10919983
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide modulates Gi-protein expression and adenylyl cyclase signaling in vascular smooth muscle cells.
Bassil M; Anand-Srivastava MB
Free Radic Biol Med; 2006 Oct; 41(7):1162-73. PubMed ID: 16962941
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms.
Hung LM; Su MJ; Chen JK
Free Radic Biol Med; 2004 Mar; 36(6):774-81. PubMed ID: 14990356
[TBL] [Abstract][Full Text] [Related]
33. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
Díaz-Troya S; Najib S; Sánchez-Margalet V
Regul Pept; 2005 Feb; 125(1-3):41-6. PubMed ID: 15582712
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells.
Chao HH; Juan SH; Liu JC; Yang HY; Yang E; Cheng TH; Shyu KG
Eur J Pharmacol; 2005 May; 515(1-3):1-9. PubMed ID: 15878161
[TBL] [Abstract][Full Text] [Related]
35. Bakuchicin induces vascular relaxation via endothelium-dependent NO-cGMP signaling.
Li X; Lee YJ; Kim YC; Jeong GS; Cui HZ; Kim HY; Kang DG; Lee HS
Phytother Res; 2011 Oct; 25(10):1574-8. PubMed ID: 21442677
[TBL] [Abstract][Full Text] [Related]
36. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression.
Fujisaki H; Ito H; Hirata Y; Tanaka M; Hata M; Lin M; Adachi S; Akimoto H; Marumo F; Hiroe M
J Clin Invest; 1995 Aug; 96(2):1059-65. PubMed ID: 7635942
[TBL] [Abstract][Full Text] [Related]
37. The ANP-cGMP-protein kinase G pathway induces a phagocytic phenotype but decreases inflammatory gene expression in microglial cells.
Borán MS; Baltrons MA; García A
Glia; 2008 Mar; 56(4):394-411. PubMed ID: 18186083
[TBL] [Abstract][Full Text] [Related]
38. Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria.
Herring N; Golding S; Paterson DJ
J Mol Cell Cardiol; 2000 Oct; 32(10):1795-804. PubMed ID: 11013124
[TBL] [Abstract][Full Text] [Related]
39. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
40. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H
J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
